Royal Bank of Canada’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2K | Sell |
2,827
-517
| -15% | -$366 | ﹤0.01% | 6428 |
|
|
2025
Q1 | $2K | Sell |
3,344
-377
| -10% | -$225 | ﹤0.01% | 6198 |
|
|
2024
Q4 | $4K | Buy |
3,721
+866
| +30% | +$931 | ﹤0.01% | 6098 |
|
|
2024
Q3 | $6K | Sell |
2,855
-84
| -3% | -$177 | ﹤0.01% | 5996 |
|
|
2024
Q2 | $11K | Buy |
2,939
+886
| +43% | +$3.32K | ﹤0.01% | 5915 |
|
|
2024
Q1 | $10K | Sell |
2,053
-6,987
| -77% | -$34K | ﹤0.01% | 5764 |
|
|
2023
Q4 | $39K | Buy |
9,040
+3,977
| +79% | +$17.2K | ﹤0.01% | 5563 |
|
|
2023
Q3 | $15K | Sell |
5,063
-216
| -4% | -$640 | ﹤0.01% | 5787 |
|
|
2023
Q2 | $24K | Buy |
5,279
+21
| +0.4% | +$95 | ﹤0.01% | 5666 |
|
|
2023
Q1 | $30K | Buy |
5,258
+959
| +22% | +$5.47K | ﹤0.01% | 5487 |
|
|
2022
Q4 | $26K | Buy |
4,299
+99
| +2% | +$599 | ﹤0.01% | 5725 |
|
|
2022
Q3 | $28K | Buy |
4,200
+1,699
| +68% | +$11.3K | ﹤0.01% | 5522 |
|
|
2022
Q2 | $13K | Sell |
2,501
-665
| -21% | -$3.46K | ﹤0.01% | 5814 |
|
|
2022
Q1 | $22K | Sell |
3,166
-1,666
| -34% | -$11.6K | ﹤0.01% | 6068 |
|
|
2021
Q4 | $61K | Sell |
4,832
-74
| -2% | -$934 | ﹤0.01% | 5719 |
|
|
2021
Q3 | $153K | Buy |
4,906
+1,250
| +34% | +$39K | ﹤0.01% | 4896 |
|
|
2021
Q2 | $104K | Buy |
3,656
+207
| +6% | +$5.89K | ﹤0.01% | 5101 |
|
|
2021
Q1 | $150K | Buy |
3,449
+618
| +22% | +$26.9K | ﹤0.01% | 4680 |
|
|
2020
Q4 | $203K | Buy |
+2,831
| New | +$203K | ﹤0.01% | 4322 |
|